These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15482138)

  • 21. [Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].
    Bernardino de la Serna JI; Mora Rillo M; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():7-12. PubMed ID: 19195432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.
    Gengiah TN; Baxter C; Mansoor LE; Kharsany AB; Abdool Karim SS
    Expert Opin Investig Drugs; 2012 May; 21(5):695-715. PubMed ID: 22394224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.
    Kiser JJ; Carten ML; Aquilante CL; Anderson PL; Wolfe P; King TM; Delahunty T; Bushman LR; Fletcher CV
    Clin Pharmacol Ther; 2008 Feb; 83(2):265-72. PubMed ID: 17597712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studies.
    Winston J; Chonchol M; Gallant J; Durr J; Canada RB; Liu H; Martin P; Patel K; Hindman J; Piontkowsky D
    HIV Clin Trials; 2014; 15(6):231-45. PubMed ID: 25433663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir trials raise ethical issues.
    Mills E
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):31-2. PubMed ID: 16365973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
    Antoniou T; Park-Wyllie LY; Tseng AL
    Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
    Muñoz de Benito RM; Arribas López JR
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
    Llibre JM; Clotet B
    AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.
    Hazra R; Balis FM; Tullio AN; DeCarlo E; Worrell CJ; Steinberg SM; Flaherty JF; Yale K; Poblenz M; Kearney BP; Zhong L; Coakley DF; Blanche S; Bresson JL; Zuckerman JA; Zeichner SL
    Antimicrob Agents Chemother; 2004 Jan; 48(1):124-9. PubMed ID: 14693529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers.
    Lu C; Jia Y; Yang J; Song Y; Liu W; Ding Y; Sun X; Wen A
    Clin Drug Investig; 2012 May; 32(5):333-8. PubMed ID: 22413748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tenofovir: pharmacology and interactions].
    Azanza JR; García Quetglas E; Sádaba B; Gómez-Giu A
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():2-6. PubMed ID: 19195431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.
    Olin JL; Spooner LM; Klibanov OM
    Ann Pharmacother; 2012 Dec; 46(12):1671-7. PubMed ID: 23136357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.
    Uglietti A; Zanaboni D; Gnarini M; Maserati R
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1305-14. PubMed ID: 22943210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
    Manfredi R; Calza L
    AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.
    Valantin MA; Bittar R; de Truchis P; Bollens D; Slama L; Giral P; Bonnefont-Rousselot D; Pétour P; Aubron-Olivier C; Costagliola D; Katlama C;
    J Antimicrob Chemother; 2010 Mar; 65(3):556-61. PubMed ID: 20053692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection.
    Hazra R; Gafni RI; Maldarelli F; Balis FM; Tullio AN; DeCarlo E; Worrell CJ; Steinberg SM; Flaherty J; Yale K; Kearney BP; Zeichner SL
    Pediatrics; 2005 Dec; 116(6):e846-54. PubMed ID: 16291735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.
    Vourvahis M; Davis J; Langdon G; Layton G; Fang J; Choo HW; Hansson AG; Tawadrous M
    Antivir Ther; 2013; 18(6):745-54. PubMed ID: 23558061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Buti M; Homs M
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):413-21. PubMed ID: 22928893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.
    Gallant JE; Rodriguez AE; Weinberg WG; Young B; Berger DS; Lim ML; Liao Q; Ross L; Johnson J; Shaefer MS;
    J Infect Dis; 2005 Dec; 192(11):1921-30. PubMed ID: 16267763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.
    Moss JA; Baum MM; Malone AM; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Willis RA; Vincent KL; Motamedi M; Smith TJ
    AIDS; 2012 Mar; 26(6):707-10. PubMed ID: 22210639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.